Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.

BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...

Detaylı Bibliyografya
Asıl Yazarlar:	Morgan, R, O'Callaghan, J, Knight, SR, Morris, P
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2012

Benzer Materyaller

Systematic reviews of alemtuzumab in renal transplantation.
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Systematic reviews of alemtuzumab in renal transplantation
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

ALEMTUZUMAB INDUCTION IN PANCREAS TRANSPLANTATION
Yazar:: Muthusamy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Systematic review of clinical practice guidelines in kidney transplantation
Yazar:: O'Donoghue, K, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.
Yazar:: Watson, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
Yazar:: Haynes, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
Yazar:: Haynes, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Alemtuzumab induction and steroid free immunosupprssion in pancreas transplantation.
Yazar:: Muthusamy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Critical appraisal of United Kingdom clinical practice guidelines in kidney transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: A systematic review
Yazar:: Knight, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis.
Yazar:: OʼCallaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation.
Yazar:: Muthusamy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Steroid-free immunosuppression in pancreas transplantation using Alemtuzumab induction
Yazar:: Muthusamy, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
Yazar:: A. Benazzo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
Yazar:: Martina Guthoff, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression.
Yazar:: Flechner, S, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Terapia de indução com alentuzumabe em receptores de transplante renal Alemtuzumab induction in kidney transplant recipients
Yazar:: Edison Luiz Mandia Sampaio, ve diğerleri
Baskı/Yayın Bilgisi: (2010-03-01)

Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
Yazar:: Haynes, R, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection
Yazar:: Lukas K. van Vugt, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
Yazar:: A Khalafi-Nezhad, ve diğerleri
Baskı/Yayın Bilgisi: (2015-10-01)

A national registry analysis of kidney allografts preserved with Marshall's Solution in the United Kingdom
Yazar:: O'Callaghan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

Kidney transplantation--the long term view.
Yazar:: O'Callaghan, C
Baskı/Yayın Bilgisi: (2008)

Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.
Yazar:: Plata-Munoz, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Evidence based hypothermic preservation of the kidney and liver for transplantation
Yazar:: O'Callaghan, JM
Baskı/Yayın Bilgisi: (2014)

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
Yazar:: Masashi Furukawa, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

The immunological bases of alemtuzumab as induction-therapy in pediatric-onset multiple sclerosis
Yazar:: Marco Puthenparampil, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
Yazar:: Adil S. Lakha, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Low incidence of lymphoproliferative disease post kidney transplantation with prevalent use of alemtuzumab
Yazar:: John Fredy Nieto-Ríos, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Transplant Trial Watch
Yazar:: John Matthew O’Callaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Prophylactic Peri-Nephric Drain Placement in Renal Transplant Surgery: A Systematic Review and Meta-Analysis
Yazar:: Lakha, AS, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Critical appraisal of International Clinical Practice Guidelines in Kidney Transplantation using the Appraisal of Guidelines for Research and Education (AGREE) II tool: a systematic review
Yazar:: O'Donoghue, K, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report
Yazar:: Naoki Okada, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Transplant Trial Watch
Yazar:: John M. O’Callaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Transplant Trial Watch
Yazar:: John M. O’Callaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Transplant Trial Watch
Yazar:: John M. O’Callaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Transplant Trial Watch
Yazar:: Simon R. Knight, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Transplant Trial Watch
Yazar:: Simon R. Knight, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Transplant Trial Watch
Yazar:: John M. O’Callaghan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)